[go: up one dir, main page]

AU2001263288A1 - Crf receptor antagonists - Google Patents

Crf receptor antagonists

Info

Publication number
AU2001263288A1
AU2001263288A1 AU2001263288A AU6328801A AU2001263288A1 AU 2001263288 A1 AU2001263288 A1 AU 2001263288A1 AU 2001263288 A AU2001263288 A AU 2001263288A AU 6328801 A AU6328801 A AU 6328801A AU 2001263288 A1 AU2001263288 A1 AU 2001263288A1
Authority
AU
Australia
Prior art keywords
receptor antagonists
crf receptor
crf
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263288A
Inventor
Jane H. Bu
Mustapha Haddach
Dragan Marinkovic
John P. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine Biosciences Inc
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of AU2001263288A1 publication Critical patent/AU2001263288A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001263288A 2000-05-18 2001-05-18 Crf receptor antagonists Abandoned AU2001263288A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US20561400P 2000-05-18 2000-05-18
US20561100P 2000-05-18 2000-05-18
US20560700P 2000-05-18 2000-05-18
US60205614 2000-05-18
US60205611 2000-05-18
US60205607 2000-05-18
PCT/US2001/016202 WO2001087892A1 (en) 2000-05-18 2001-05-18 Crf receptor antagonists

Publications (1)

Publication Number Publication Date
AU2001263288A1 true AU2001263288A1 (en) 2001-11-26

Family

ID=27394819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263288A Abandoned AU2001263288A1 (en) 2000-05-18 2001-05-18 Crf receptor antagonists

Country Status (5)

Country Link
US (2) US6440960B1 (en)
EP (1) EP1287002A1 (en)
JP (1) JP2003533530A (en)
AU (1) AU2001263288A1 (en)
WO (1) WO2001087892A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273871B2 (en) * 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
CN102558155A (en) 2003-01-14 2012-07-11 阿伦纳药品公司 Aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of diseases related thereto, such as diabetes and hyperglycemia
AU2004257267B2 (en) 2003-07-14 2009-12-03 Arena Pharmaceuticals,Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
EA201390421A1 (en) 2010-09-22 2013-09-30 Арена Фармасьютикалз, Инк. GPR119 RECEPTOR MODULATORS AND TREATMENT OF RELATED DISORDERS
EP4445956A3 (en) 2015-01-06 2024-12-04 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
PL3310760T3 (en) 2015-06-22 2023-03-06 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders
CN110520124A (en) 2017-02-16 2019-11-29 艾尼纳制药公司 For treating the Compounds and methods for of primary biliary cholangitis
CA3102136A1 (en) 2018-06-06 2019-12-12 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973884B (en) * 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
IL127566A0 (en) * 1996-08-28 1999-10-28 Pfizer Substituted 6,5-hetero- bicyclic derivatives
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
ATE225349T1 (en) 1998-11-12 2002-10-15 Neurocrine Biosciences Inc CRF RECEPTOR ANTAGONISTS AND RELATED METHODS

Also Published As

Publication number Publication date
JP2003533530A (en) 2003-11-11
US20030055050A1 (en) 2003-03-20
EP1287002A1 (en) 2003-03-05
WO2001087892A1 (en) 2001-11-22
US6440960B1 (en) 2002-08-27
US20020049203A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001264657A1 (en) Crf receptor antagonists
AU2001255798A1 (en) Glucagon antagonists
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
AU2001273032A1 (en) Cytokine receptor zcytor17
AU4331500A (en) Pyrazolotriazines as crf antagonists
AU2441801A (en) Urotensin-ii receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU2001245724A1 (en) Il-8 receptor antagonists
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists
AU2001263288A1 (en) Crf receptor antagonists
AU2001240097A1 (en) G protein-coupled receptors
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU2001249573A1 (en) Chemokine receptor antagonists
AU2001241896A1 (en) Il-8 receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
AU2001223882A1 (en) Receptor
AU2001249922A1 (en) G protein-coupled receptors
AU2001245605A1 (en) Il-8 receptor antagonists
AUPQ563400A0 (en) Novel receptor
AU6051200A (en) Il-8 receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
AU2001259322A1 (en) G protein-coupled receptors